I. Vincent

Interactions between Atazanavir-Ritonavir and Tenofovir in Heavily Pretreated Human Immunodeficiency Virus-Infected Patients

V. Calvez, F. Clavel, A. Taburet, 2004, Antimicrobial Agents and Chemotherapy.

Single-Dose Pharmacokinetics of Amprenavir Coadministered with Grapefruit Juice

A. Taburet, I. Vincent, C. Gillotin, 2002, Antimicrobial Agents and Chemotherapy.

Interactions Between Amprenavir and the Lopinavir‐ritonavir Combination in Heavily Pretreated Patients Infected with Human Immunodeficiency Virus

F. Clavel, G. Chêne, C. Droz, 2004, Clinical pharmacology and therapeutics.

Impairment of Drug Biotransformation in Renal Disease: An In Vitro Model

V. Furlan, A. Taburet, I. Vincent, 1996 .

Steady-State Pharmacokinetics of Amprenavir Coadministered with Ritonavir in Human Immunodeficiency Virus Type 1-Infected Patients

C. Goujard, A. Taburet, J. Meynard, 2003, Antimicrobial Agents and Chemotherapy.

Interaction between theophylline and tacrolimus in a renal transplant patient.

O. Lambotte, B. Charpentier, C. Hiesse, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Determination of Amprenavir Total and Unbound Concentrations in Plasma by High-Performance Liquid Chromatography and Ultrafiltration

V. Furlan, A. Taburet, I. Vincent, 2006, Therapeutic drug monitoring.

High Variability of Indinavir and Nelfinavir Pharmacokinetics in HIV-infected Patients with a Sustained Virological Response on Highly Active Antiretroviral Therapy

France Mentré, Xavier Duval, Christine Katlama, 2005, Clinical pharmacokinetics.

Effect of Highly Active Antiretroviral Therapy on Tacrolimus Pharmacokinetics in Hepatitis C Virus and HIV Co-Infected Liver Transplant Recipients in the ANRS HC-08 Study

D. Samuel, L. Bonhomme-Faivre, D. Vittecoq, 2007, Clinical pharmacokinetics.

Life‐threatening interaction between antiretroviral therapy and vinblastine in HIV‐associated multicentric Castleman's disease

R. Kotb, C. Goujard, J. Delfraissy, 2006, European journal of haematology.

Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective long-term therapy.

K. Setchell, E. Jacquemin, M. Fabre, 2009, Gastroenterology.

54 – Traitement de l'infection par le virus de l'immunodéficience humaine

C. Goujard, A. Taburet, I. Vincent, 2008 .

Lack of removal of nelfinavir during a haemodialysis session in an HIV-1 infected patient with hepatic and renal insufficiency.

B. Charpentier, C. Goujard, A. Taburet, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

ral Cholic Acid for Hereditary Defects of Primary Bile Acid Synthesis : Safe and Effective Long-term Therapy

K. Setchell, M. Fabre, J. Heubi, 2009 .